Rapid and Highly Sensitive Detection of Fluorescently-labeled Troponin in Patients Admitted With Chest Pain
NCT ID: NCT02897492
Last Updated: 2019-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2016-09-01
2019-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
NCT02984436
Troponin to Risk Stratify Patients for Computed Tomography Coronary Angiography
NCT04549805
Using Higher Cut-off Values to Diagnose Acute Myocardial Infarction in Patients With Elevated Hs-cTnT Concentrations
NCT06059079
Quantification and Description of the Increase in Serum Troponin Following Acute Coronary Syndrome
NCT01698021
High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome
NCT01852123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A new diagnostic method will be applicated in the recent studies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood testing in a newly described method
To exploit detection strategy termed "Magnetic Modulation Biosensing", or MMB) to develop a novel, low-cost platform that can detect biomarkers, such as proteins and specific DNA sequences, rapidly and directly from real samples at very low concentrations.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Admitted to Rambam health campus for the investigation of chest pain
18 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
rambam75
Dr Shadi Hamoud
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rapid troponin detection
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.